Nervous system Lyme disease

Handbook of Clinical Neurology

Volumn 121, Issue , 2014, Pages 1473-1483

  Halperin, John J ^a  

^a Overlook Medical Center   (United States)

Author keywords

Borrelia burgdorferi; Diagnosis; Garin Bujadoux Bannwarth syndrome; Intrathecal antibody production; Lyme borreliosis; Lyme disease; Neuroborreliosis; Treatment

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; BORRELIA BURGDORFERI; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; GARIN-BUJADOUX-BANNWARTH SYNDROME; HISTORY; HUMAN; INTRATHECAL ANTIBODY PRODUCTION; LYME DISEASE; MICROBIOLOGY; NEUROBORRELIOSIS; NEUROIMAGING; PATHOLOGY; TREATMENT;

BORRELIA BURGDORFERI; DIAGNOSIS; GARIN-BUJADOUX-BANNWARTH SYNDROME; INTRATHECAL ANTIBODY PRODUCTION; LYME BORRELIOSIS; LYME DISEASE; NEUROBORRELIOSIS; TREATMENT;

ANTI-BACTERIAL AGENTS; BORRELIA BURGDORFERI; DIAGNOSIS, DIFFERENTIAL; HISTORY, 20TH CENTURY; HUMANS; LYME NEUROBORRELIOSIS; NEUROIMAGING;

EID: 84890850881     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4088-7.00099-7     Document Type: Chapter

References (74)

1. Ackermann R., Rehse K.B., Gollmer E., et al. Chronic neurologic manifestations of erythema migrans borreliosis. Ann. N. Y. Acad. Sci. 1988, 539:16-23.
2. Afzelius A. Verhandlugen der dermatorischen Gesellshaft zu Stockholm. Arch. Derm. Syphiligr. 1910, 101:404.
3. Aguero-Rosenfeld M.E., Nowakowski J., Bittker S., et al. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J. Clin. Microbiol. 1996, 34:1-9.
4. Bacon R.M., Kugeler K.J., Griffith K.S., et al. Lyme disease - United States 2003-2005. MMWR Morb. Mortal. Wkly Rep. 2007, 56:573-576.
5. Bacon R.M., Kugeler K.J., Mead P.S. Surveillance for Lyme disease - United States 1992-2006. MMWR Morb. Mortal. Wkly Rep. 2008, 57:1-9.
6. Bannwarth A. Chronische lymphocytare meningitis entzundliche polyneuritis und rheumatismus. Arch. Psychiatr. Nervenkr. 1941, 113:284-376.
7. Belman A.L., Iyer M., Coyle P.K., et al. Neurologic manifestations in children with North American Lyme disease. Neurology 1993, 43:2609-2614.
8. Benach J.L., Bosler E.M., Hanrahan J.P., et al. Spirochetes isolated from the blood of two patients with Lyme disease. N. Engl. J. Med. 1983, 308:740-742.
9. Bertrand E., Szpak G.M., Pilkowska E., et al. Central nervous system infection caused by Borrelia burgdorferi. Clinico-pathological correlation of three post-mortem cases. Folia Neuropathol. 1999, 37:43-51.
10. Burgdorfer W., Barbour A.G., Hayes S.F., et al. Lyme disease: a tick borne spirochetosis?. Science 1982, 216:1317-1319.
11. Cadavid D., O'Neill T., Schaefer H., et al. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease. Lab. Invest. 2000, 80:1043-1054.
12. Cameron D., Gaito A., Harris N. Evidence-based guidelines for the management of Lyme disease. Expert Rev. Anti Infect. Ther. 2004, 2:S1-S13. ILADS Working Group.
13. Centers for Disease Control and Prevention (CDC) Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb. Mortal. Wkly Rep. 1995, 44:590-591.
14. Cerar D., Cerar T., Ruzic-Sabljic E., et al. Subjective symptoms after treatment of early Lyme disease. Am. J. Med. 2010, 123:79-86.
15. Dattwyler R.J., Volkman D.J., Luft B.J., et al. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N. Engl. J. Med. 1988, 319:1441-1446.
16. England J.D., Bohm R.P., Roberts E.D., et al. Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann. Neurol. 1997, 41:375-384.
17. Fallon B.A., Keilp J.G., Corbera K.M., et al. A randomized placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008, 70:992-1003.
18. Feder H.M., Johnson B.J., O'Connell S., et al. A critical appraisal of chronic Lyme disease. N. Engl. J. Med. 2007, 357:1422-1430.
19. Garcia-Monco J.C., Fernandez-Villar B., Benach J.L. Adherence of the Lyme disease spirochete to glial cells and cells of glial origin. J. Infect. Dis. 1989, 160:497-506.
20. Garin C., Bujadoux A. Paralysie par les tiques. J. Med. Lyon 1922, 71:765-767.
21. Halperin J.J. Facial nerve palsy associated with Lyme disease. Muscle Nerve 2003, 28:516-517.
22. Halperin J.J. Nervous system Lyme disease. J. R. Coll. Physicians Edinb. 2010, 40:248-255.
23. Halperin J.J., Heyes M.P. Neuroactive kynurenines in Lyme borreliosis. Neurology 1992, 42:43-50.
24. Halperin J.J., Little B.W., Coyle P.K., et al. Lyme disease - a treatable cause of peripheral neuropathy. Neurology 1987, 37:1700-1706.
25. Halperin J.J., Pass H.L., Anand A.K., et al. Nervous system abnormalities in Lyme disease. Ann. N. Y. Acad. Sci. 1988, 539:24-34.
26. Halperin J.J., Luft B.J., Anand A.K., et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology 1989, 39:753-759.
27. Halperin J.J., Krupp L.B., Golightly M.G., et al. Lyme borreliosis-associated encephalopathy. Neurology 1990, 40:1340-1343.
28. Halperin J.J., Luft B.J., Volkman D.J., et al. Lyme neuroborreliosis - peripheral nervous system manifestations. Brain 1990, 113:1207-1221.
29. Halperin J.J., Golightly M. Lyme borreliosis in Bell's palsy. Neurology 1990, 40:342. Long Island Neuroborreliosis Collaborative Study Group.
30. Halperin J.J., Shapiro E.D., Logigian E.L., et al. Practice parameter: treatment of nervous system Lyme disease. Neurology 2007, 69:91-102.
31. Hammers Berggren S., Hansen K., Lebech A.M., et al. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology 1993, 43:169-175.
32. Hansen K., Lebech A.M. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992, 115:399-423.
33. Hansen K., Cruz M., Link H. Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis. J. Infect. Dis. 1990, 161:1194-1202.
34. Henriksson A., Link H., Cruz M., et al. Immunoglobulin abnormalities in cerebrospinal fluid and blood over the course of lymphocytic meningoradiculitis (Bannwarth's syndrome). Ann. Neurol. 1986, 20:337-345.
35. Hollstrom E. Successful treatment of erythema migrans Afzelius. Acta Derm. Venereol. 1951, 31:235-243.
36. Jacobson D.M., Frens D.B. Pseudotumor cerebri syndrome associated with Lyme disease. Am. J. Ophthalmol. 1989, 107:81-82.
37. Kalina P., Decker A., Kornel E., et al. Lyme disease of the brainstem. Neuroradiology 2005, 47:903-907.
38. Karlsson M., Hovind H.K., Svenungsson B., et al. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J. Clin. Microbiol. 1990, 28:473-479.
39. Keller T.L., Halperin J.J., Whitman M. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology 1992, 42:32-42.
40. Klempner M.S., Hu L.T., Evans J., et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med. 2001, 345:85-92.
41. Krupp L.B., Masur D., Schwartz J., et al. Cognitive functioning in late Lyme borreliosis. Arch. Neurol. 1991, 48:1125-1129.
42. Krupp L.B., Hyman L.G., Grimson R., et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003, 60:1923-1930.
43. Logigian E.L., Kaplan R.F., Steere A.C. Chronic neurologic manifestations of Lyme disease. N. Engl. J. Med. 1990, 323:1438-1444.
44. Logigian E.L., Johnson K.A., Kijewski M.F., et al. Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology 1997, 49:1661-1670.
45. Luft B.J., Steinman C.R., Neimark H.C., et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 1992, 267:1364-1367.
46. Luo N., Johnson J., Shaw J., et al. Self-reported health status of the general adult US population as assessed by the EQ-5D and Health Utilities Index. Med. Care 2005, 43:1078-1086.
47. Meier C., Grahmann F., Engelhardt A., et al. Peripheral nerve disorders in Lyme-borreliosis. Nerve biopsy studies from eight cases. Acta Neuropathol. (Berl) 1989, 79:271-278.
48. Muley S.A., Parry G.J. Antibiotic responsive demyelinating neuropathy related to Lyme disease. Neurology 2009, 72:1786-1787.
49. Nowakowski J., Schwartz I., Liveris D., et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin. Infect. Dis. 2001, 33:2023-2027.
50. Oksi J., Kalimo H., Marttila R.J., et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 1996, 119:2143-2154.
51. Oksi J., Nikoskelainen J., Hiekkanen H., et al. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind randomized placebo-controlled multicenter clinical study. Eur J Clin Microbiol Infect Dis 2007, 26(6):571-581.
52. Pachner A.R., Delaney E., O'Neill T., et al. Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology 1995, 45:165-172.
53. Pfister H.W., Einhaupl K.M., Franz P., et al. Corticosteroids for radicular pain in Bannwarth's syndrome: a double blind randomized placebo controlled trial. Ann. N. Y. Acad. Sci. 1988, 539:485-487.
54. Philipp M.T., Aydintug M.K., Bohm R.J., et al. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect. Immun. 1993, 61:3047-3059.
55. Piesman J., Dolan M.C. Protection against Lyme disease spirochete transmission provided by prompt removal of nymphal Ixodes scapularis (Acari: Ixodidae). J. Med. Entomol. 2002, 39:509-512.
56. Reik L., Steere A.C., Bartenhagen N.H., et al. Neurologic abnormalities of Lyme disease. Medicine 1979, 58:281-294.
57. Rupprecht T.A., Koedel U., Fingerle V., et al. The pathogenesis of Lyme neuroborreliosis: from infection to inflammation. Mol. Med. 2008, 14:205-212.
58. Rupprecht T.A., Plate A., Adam M., et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J. Neuroinflammation 2009, 6:42.
59. Scrimenti R.J. Erythema chronicum migrans. Arch. Dermatol. 1970, 102:104-105.
60. Shah S.S., Zaoutis T.E., Turnquist J., et al. Early differentiation of Lyme from enteroviral meningitis. Pediatr. Infect. Dis. J. 2005, 24:542-545.
61. Sibony P., Halperin J., Coyle P., et al. Reactive Lyme serology in patients with optic neuritis and papilledema. J. Neuroophthal. 2005, 25:71-82.
62. Skogman B.H., Croner S., Nordwall M., et al. Lyme neuroborreliosis in children: a prospective study of clinical features prognosis and outcome. Pediatr. Infect. Dis. J. 2008, 27:1089-1094.
63. Steere A.C., Malawista S.E., Hardin J.A., et al. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann. Intern. Med. 1977, 86:685-698.
64. Steere A.C., Bartenhagen N.H., Craft J.E., et al. The early clinical manifestations of Lyme disease. Ann. Intern. Med. 1983, 99:76-82.
65. Steere A.C., Grodzicki R.L., Kornblatt A.N., et al. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 1983, 308:733-740.
66. Steere A.C., Pachner A.R., Malawista S.E. Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann. Intern. Med. 1983, 99:767-772.
67. Steere A.C., Berardi V.P., Weeks K.E., et al. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J. Infect. Dis. 1990, 161:1203-1209.
68. Stiernstedt G., Gustafsson R., Karlsson M., et al. Clinical manifestations and diagnosis of neuroborreliosis. Ann. N. Y. Acad. Sci. 1988, 539:46-55.
69. Sullivan F.M., Swan I.R., Donnan P.T., et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N. Engl. J. Med. 2007, 357:1598-1607.
70. Tuerlinckx D., Bodart E., Garrino M.G., et al. Clinical data and cerebrospinal fluid findings in Lyme meningitis versus aseptic meningitis. Eur. J. Pediatr. 2003, 162:150-153.
71. Tuerlinckx D., Bodart E., Jamart J., et al. Prediction of Lyme meningitis based on a logistic regression model using clinical and cerebrospinal fluid analysis: a European study. Pediatr. Infect. Dis. J. 2009, 28:394-397.
72. Vallat J.M., Hugon J., Lubeau M., et al. Tick bite meningoradiculoneuritis. Neurology 1987, 37:749-753.
73. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment treatment and prevention of Lyme disease human granulocytic anaplasmosis and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 2006, 43:1089-1134.
74. Zemel L. Lyme disease and pseudotumor. Mayo Clin. Proc. 2000, 75:315.